AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
55.16
-0.54 (-0.97%)
At close: Sep 10, 2026, 4:00 PM EDT
54.39
-0.77 (-1.40%)
After-hours: Sep 10, 2026, 5:36 PM EDT
AnaptysBio Market Cap
AnaptysBio has a market cap or net worth of $1.63 billion as of September 10, 2026. Its market cap has increased by 163.59% in one year.
Market Cap
1.63B
Enterprise Value
1.62B
1-Year Change
163.59%
Ranking
Category
Stock Price
$55.16
ChartMarket Cap Chart
Since January 26, 2017, AnaptysBio's market cap has increased from $308.70M to $1.63B, an increase of 429.06%. That is a compound annual growth rate of 18.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 1.63B | 21.67% |
| Dec 31, 2025 | 1.34B | 233.16% |
| Dec 31, 2024 | 402.90M | -29.22% |
| Dec 29, 2023 | 569.20M | -35.40% |
| Dec 30, 2022 | 881.10M | -7.83% |
| Dec 31, 2021 | 955.90M | 62.57% |
| Dec 31, 2020 | 588.00M | 33.36% |
| Dec 31, 2019 | 440.90M | -74.16% |
| Dec 31, 2018 | 1.71B | -27.90% |
| Dec 29, 2017 | 2.37B | 666.67% |
| Jan 26, 2017 | 308.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syndax Pharmaceuticals | 1.78B |
| Septerna | 1.74B |
| Inhibrx Biosciences | 1.68B |
| Novavax | 1.68B |
| Avalyn Pharma | 1.67B |
| Fortrea Holdings | 1.62B |
| Ascentage Pharma Group International | 1.60B |
| Apnimed | 1.60B |